U.S. Markets open in 9 hrs 28 mins

NRx Pharmaceuticals, Inc. (NRXP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
6.68+1.27 (+23.48%)
At close: 04:00PM EST
6.67 -0.01 (-0.15%)
After hours: 07:59PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 376.99
52 Week Low 34.07
50-Day Moving Average 38.46
200-Day Moving Average 319.37

Share Statistics

Avg Vol (3 month) 34.26M
Avg Vol (10 day) 310.53M
Shares Outstanding 547.46M
Implied Shares Outstanding 6N/A
Float 818.03M
% Held by Insiders 164.98%
% Held by Institutions 14.00%
Shares Short (Sep 29, 2021) 41.7M
Short Ratio (Sep 29, 2021) 41.11
Short % of Float (Sep 29, 2021) 4N/A
Short % of Shares Outstanding (Sep 29, 2021) 43.16%
Shares Short (prior month Aug 30, 2021) 42.26M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -28.79M
Net Income Avi to Common (ttm)-347.61M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.39M
Total Cash Per Share (mrq)0.28
Total Debt (mrq)686.17k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.52
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-15.95M
Levered Free Cash Flow (ttm)N/A